Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;22(1):9-22.
doi: 10.1111/1751-2980.12937.

Histological scores in inflammatory bowel disease

Benedetto Neri  1 , Michelangela Mossa  1 , Ludovica Scucchi  1 , Giorgia Sena  1 , Giampiero Palmieri  2 , Livia Biancone  1
Affiliations
Review

Histological scores in inflammatory bowel disease

Benedetto Neri et al. J Dig Dis. 2021 Jan.

Abstract

The role of histology in inflammatory bowel disease (IBD) has not yet been well defined. Endoscopic mucosal healing has been proposed as a predictor of the clinical course of IBD and it is indeed considered one of the main therapeutic targets. However, it does not necessarily imply histological healing. Histological remission has been reported to be associated with a better clinical outcome than endoscopic remission only in IBD patients. These observations support the view that histology plays a role as a potential therapeutic target in Crohn's disease and ulcerative colitis. Histological scores being able to quantify the degree of microscopic activity are needed for this purpose. In the era of biologics, indication for proper treatment may benefit from the assessment of clinical and endoscopic activity, as well as histological scores. Such scores may allow us to quantify the microscopic mucosal response to treatment and to define complete healing in IBD. A validated histological score in IBD may lead to the definition of microscopic activity in clinical practice, trials and investigational settings. Several attempts to develop such scores have been reported, but few are currently used and none is applied worldwide in clinical practice. The present review summarizes the main histological scores currently used for assessing IBD activity.

Keywords: histology; inflammatory bowel diseases; microscopic activity; prognostic factor; therapeutic target.

PubMed Disclaimer

References

REFERENCES

    1. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12(Suppl 1):S3-S9.
    1. Magro F, Gionchetti P, Eliakim R, et al; European Crohn’s and Colitis Organisation [ECCO]. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo−anal pouch disorders. J Crohns Colitis. 2017;11(6):649-670.
    1. Gionchetti P, Dignass A, Danese S, ECCO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 2: surgical management and special situations. J Crohns Colitis. 2017;11(2):135-149.
    1. Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity inulcerative colitis: what does it mean? Gut. 1991;32(2):174-178.
    1. Rosenberg L, Nanda KS, Zenlea T, et al. Histologic markers of inflammation in patients with ulcerative colitis in clinical remission. Clin Gastroenterol Hepatol. 2013;11(8):991-996.

LinkOut - more resources